Salivary gland hypofunction in patients with advanced cancer

Oral Oncology

Volumn 38, Issue 7, 2002, Pages 680-685

  Davies, Andrew N ^a   Broadley, Karen ^b   Beighton, David ^c  

^a BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Neoplasms; Palliative care; Salivary gland diseases; Xerostomia

Indexed keywords

ANALGESIC AGENT; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPHAGIA; DYSPHONIA; FEMALE; FLOW RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; SALIVARY GLAND DISEASE; SALIVATION; XEROSTOMIA; AGE; DRUG EFFECT; MIDDLE AGED; NEOPLASM; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; SALIVA; SECRETION; SEX DIFFERENCE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMAN; MALE; MIDDLE AGE; NEOPLASMS; PROSPECTIVE STUDIES; SALIVA; SALIVARY GLAND DISEASES; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; XEROSTOMIA; HUMANS; MIDDLE AGED;

EID: 0036024537     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(01)00133-6     Document Type: Article

References (28)

1. Clinical criteria for the diagnosis of salivary gland hypofunction
2. Xerostomia: Diagnosis, management and clinical complications
3. Physiological factors affecting salivary flow rate, oral sugar clearance, and the sensation of dry mouth in man
4. Diagnosis and management of the dry mouth: Part 1
5. Prediction of survival of patients terminally ill with cancer
6. Oral and dental disease in terminally ill cancer patients
7. Oral symptoms and candida in the terminally ill
8. Clinical symptoms and length of survival in patients with terminal cancer
9. Symptom prevalence in the last week of life
10. A study of the relative frequency and importance of gastrointestinal symptoms, and weakness in patients with far advanced cancer: Student paper
11. Quality-of-life assessment during a palliative care programme
12. Common symptoms in patients with advanced cancer
13. Principles governing the use of cancer chemotherapy in palliative care
14. The Memorial Symptom Assessment Scale: An instrument for the evaluation of symptom prevalence, characteristics and distress
15. Saliva: Its role in health and disease. FDI Working Group 10 of the Commission on Oral Health, Research and Epidemiology (CORE)
16. A reference guide to drugs and dry mouth - 2nd ed
17. Oral disease in terminally ill cancer patients with xerostomia
18. Salivary flow and its relation with oral symptoms in terminally ill patients
19. Xerostomia. Part II: Relationship to nonoral symptoms, drugs, and diseases
20. Oral side-effects of the most frequently prescribed drugs
21. Salivary flow, saliva, pH and buffering capacity in 70-year-old men and women
22. Investigation of the clinical value of total saliva flow rates
23. Role of salivary mucins in the protection of the oral cavity
24. The management of xerostomia: A review
25. A comparison of artificial saliva and pilocarpine in radiation induced xerostomia
26. Candida albicans levels in patients with Sjogren's syndrome before and after long-term use of pilocarpine hydrochloride: A pilot study
27. Effect of the application of a mucin-based saliva substitute on the oral microflora of xerostomic patients